The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
dc.citation.firstpage | 645 | en_US |
dc.citation.issueNumber | 3 | en_US |
dc.citation.journalTitle | Molecular Therapy | en_US |
dc.citation.lastpage | 654 | en_US |
dc.citation.volumeNumber | 24 | en_US |
dc.contributor.author | Lee, Ciaran M. | en_US |
dc.contributor.author | Cradick, Thomas J. | en_US |
dc.contributor.author | Bao, Gang | en_US |
dc.contributor.org | Bioengineering | en_US |
dc.date.accessioned | 2017-05-04T18:16:35Z | en_US |
dc.date.available | 2017-05-04T18:16:35Z | en_US |
dc.date.issued | 2016 | en_US |
dc.description.abstract | The clustered regularly-interspaced short palindromic repeats (CRISPR)—CRISPR-associated (Cas) system from Streptococcus pyogenes (Spy) has been successfully adapted for RNA-guided genome editing in a wide range of organisms. However, numerous reports have indicated that Spy CRISPR-Cas9 systems may have significant off-target cleavage of genomic DNA sequences differing from the intended on-target site. Here, we report the performance of the Neisseria meningitidis (Nme) CRISPR-Cas9 system that requires a longer protospacer-adjacent motif for site-specific cleavage, and present a comparison between the Spy and Nme CRISPR-Cas9 systems targeting the same protospacer sequence. The results with the native crRNA and tracrRNA as well as a chimeric single guide RNA for the Nme CRISPR-Cas9 system were also compared. Our results suggest that, compared with the Spy system, the Nme CRISPR-Cas9 system has similar or lower on-target cleavage activity but a reduced overall off-target effect on a genomic level when sites containing three or fewer mismatches are considered. Thus, the Nme CRISPR-Cas9 system may represent a safer alternative for precision genome engineering applications. | en_US |
dc.identifier.citation | Lee, Ciaran M., Cradick, Thomas J. and Bao, Gang. "The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells." <i>Molecular Therapy,</i> 24, no. 3 (2016) Elsevier: 645-654. https://doi.org/10.1038/mt.2016.8. | en_US |
dc.identifier.doi | https://doi.org/10.1038/mt.2016.8 | en_US |
dc.identifier.uri | https://hdl.handle.net/1911/94171 | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
dc.title | The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells | en_US |
dc.type | Journal article | en_US |
dc.type.dcmi | Text | en_US |
dc.type.publication | publisher version | en_US |
Files
Original bundle
1 - 1 of 1